4.01 USD
↘ 0.10 (2.43%)LIVE (AS OF 10:32 AM EDT)
NRX Pharmaceuticals, Inc. Common Stock
NRXPNASDAQ • USD
Market: OPEN
NRX Pharmaceuticals, Inc. Common Stock (NRXP) is currently trading at $4.01. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (177.6%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 23, 2026.
Open?$4.11
High?$4.18
Low?$3.96
Prev. Close?$4.11
Volume?202.7K
Avg. Volume?841.5K
VWAP?$4.03
Rel. Volume?0.24x
Bid / Ask
Bid?$4.00 × 400
Ask?$4.02 × 200
Spread?$0.02
Midpoint?$4.01
Valuation & Ratios
Market Cap?175.9M
Shares Out?36.2M
Float?31.0M
Float %?85.6%
P/E Ratio?N/A
P/B Ratio?-12.73
EPS?-$0.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Address
1201 ORANGE STREET
WILMINGTON, DE 19801
Phone: 484-254-6134
WILMINGTON, DE 19801
Phone: 484-254-6134
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?62
Short Sent.?56
Piotroski F-Score?0/9Weak
Altman Z-Score?-38.51Distress
Confidence?46%Low
Short InterestHigh
Short % of Float?17.40%High
Short Interest?5.4M
Days to Cover?5.4
Free Float31.0M
Avg Daily Volume1.0M
Settlement Date2026-06-30
Financial Health
Current Ratio?0.29Weak
Quick Ratio?0.29Weak
Cash Ratio?0.27Low
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-12.73CHEAP▾
S&P97
P/S?76.72HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-9.9CHEAP▾
S&P97
EV/Sales?73.79HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?177.6%STRONG▾
Peers50
S&P97
ROA?-206.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$169.2M
Fundamentals ratios updated end of day